AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
CHARACTERIZATION OF THE ERYTHROPOIESIS IN MYELODYSPLASIA BY MEANS OF FERROKINETIC STUDIES, IN-VITRO ERYTHROID COLONY FORMATION AND SOLUBLE TRANSFERRIN RECEPTOR
Authors: BRADA SJL DEWOLF JTM HENDRIKS D LOUWES H VANDENBERG E VELLENGA E
Citation: Sjl. Brada et al., CHARACTERIZATION OF THE ERYTHROPOIESIS IN MYELODYSPLASIA BY MEANS OF FERROKINETIC STUDIES, IN-VITRO ERYTHROID COLONY FORMATION AND SOLUBLE TRANSFERRIN RECEPTOR, Leukemia, 12(3), 1998, pp. 340-345
EFFECTIVE TREATMENT OF SEVERE BLEEDING DUE TO ACQUIRED THROMBOCYTOPATHIA BY SINGLE-DOSE ADMINISTRATION OF ACTIVATED RECOMBINANT FACTOR-VII
Authors: MEIJER K SIEDERS E SLOOFF MJH DEWOLF JTM VANDERMEER J
Citation: K. Meijer et al., EFFECTIVE TREATMENT OF SEVERE BLEEDING DUE TO ACQUIRED THROMBOCYTOPATHIA BY SINGLE-DOSE ADMINISTRATION OF ACTIVATED RECOMBINANT FACTOR-VII, Thrombosis and haemostasis, 80(1), 1998, pp. 204-205
ISCHEMIC COLITIS AND LUNG INFILTRATES CAUSED BY EXTRAMEDULLARY HEMATOPOIESIS IN A PATIENT WITH AN ACUTE ERYTHROID LEUKEMIA FOLLOWING POLYCYTHEMIA-VERA
Authors: BRADA SJL DEWOLF JTM POPPEMA S VELLENGA E
Citation: Sjl. Brada et al., ISCHEMIC COLITIS AND LUNG INFILTRATES CAUSED BY EXTRAMEDULLARY HEMATOPOIESIS IN A PATIENT WITH AN ACUTE ERYTHROID LEUKEMIA FOLLOWING POLYCYTHEMIA-VERA, Netherlands journal of medicine, 52(4), 1998, pp. 142-146
EX-VIVO EXPANSION OF MEGAKARYOCYTIC CELLS FROM PERIPHERAL-BLOOD STEM-CELLS
Authors: DRAYER AL HENDRICKS DW DEWOLF JTM VELLENGA E SIBLINGA CTS
Citation: Al. Drayer et al., EX-VIVO EXPANSION OF MEGAKARYOCYTIC CELLS FROM PERIPHERAL-BLOOD STEM-CELLS, Transfusion, 38(10), 1998, pp. 98-98
NO INCREASE OF APOPTOSIS CAN BE OBSERVED IN BONE-MARROW HISTOLOGY BY TUNEL AND ELECTRON-MICROSCOPY IN MYELODYSPLASIA PATIENTS
Authors: BRADA SJL KOUDSTAAL J POPPEMA S BLOM N DEWOLF JTM HENDRIKS D LOUWES H SMIT JV VELLENGA E
Citation: Sjl. Brada et al., NO INCREASE OF APOPTOSIS CAN BE OBSERVED IN BONE-MARROW HISTOLOGY BY TUNEL AND ELECTRON-MICROSCOPY IN MYELODYSPLASIA PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 340-340
CHARACTERIZATION OF THE ERYTHROPOIESIS IN MYELODYSPLASIA BY MEANS OF FERROKINETIC STUDIES, IN-VITRO ERYTHROID COLONY FORMATION AND SOLUBLE TRANSFERRIN RECEPTOR
Authors: BRADA JL DEWOLF JTM HENDRIKS D LOUWES H VANDENBERG E VELLENGA E
Citation: Jl. Brada et al., CHARACTERIZATION OF THE ERYTHROPOIESIS IN MYELODYSPLASIA BY MEANS OF FERROKINETIC STUDIES, IN-VITRO ERYTHROID COLONY FORMATION AND SOLUBLE TRANSFERRIN RECEPTOR, British Journal of Haematology, 102(1), 1998, pp. 341-341
PLATELET KINETIC-STUDIES IN PATIENTS DIAGNOSED AS IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP)
Authors: LOUWES H DEWOLF JTM LATHORI OAZ VELLENGA E
Citation: H. Louwes et al., PLATELET KINETIC-STUDIES IN PATIENTS DIAGNOSED AS IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP), British Journal of Haematology, 102(1), 1998, pp. 362-362
PYRIDOXIN-RESPONSIVE ANEMIA IN A PATIENT WITH A HISTORY OF POLYCYTHEMIA-VERA
Authors: VANGAMEREN II WIJNJA L LOUWES H DEWOLF JTM
Citation: Ii. Vangameren et al., PYRIDOXIN-RESPONSIVE ANEMIA IN A PATIENT WITH A HISTORY OF POLYCYTHEMIA-VERA, Journal of internal medicine, 242(1), 1997, pp. 79-81
AUTOLOGOUS BLOOD (CELL SAVER) INCREASES THE USE OF RED-BLOOD-CELL CONCENTRATES IN LIVER-TRANSPLANTATION
Authors: HENDRIKS HGD CHOUDHURY N KLOMPMAKER IJ HAGENAARS A VANDEMEER J DEWOLF JTM
Citation: Hgd. Hendriks et al., AUTOLOGOUS BLOOD (CELL SAVER) INCREASES THE USE OF RED-BLOOD-CELL CONCENTRATES IN LIVER-TRANSPLANTATION, Thrombosis and haemostasis, 1997, pp. 951-951
LARGE DOSE OF HES-6-PERCENT-200 0.5 AS SUBSTITUTE FOR PLASMA AND ITS EFFECT ON BLOOD-LOSS IN CARDIAC-SURGERY/
Authors: EINDHOVEN GB HAGENAARS A BARNS JL BOONSTRA PW DEWOLF JTM
Citation: Gb. Eindhoven et al., LARGE DOSE OF HES-6-PERCENT-200 0.5 AS SUBSTITUTE FOR PLASMA AND ITS EFFECT ON BLOOD-LOSS IN CARDIAC-SURGERY/, Thrombosis and haemostasis, 1997, pp. 953-953
HES-6-PERCENT-200 0.5 CAN BE USED SAFELY BEYOND THE DOSE LIMIT OF 33 ML/KG/
Authors: ENDHOVEN GB HAGENAARS A BARNS JL BOONSTRA PW DEWOLF JTM
Citation: Gb. Endhoven et al., HES-6-PERCENT-200 0.5 CAN BE USED SAFELY BEYOND THE DOSE LIMIT OF 33 ML/KG/, Thrombosis and haemostasis, 1997, pp. 961-961
CONSOLIDATION THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PLASMA-CELL LEUKEMIA AFTER VAD, HIGH-DOSE CYCLOPHOSPHAMIDE AND EDAP COURSES - A REPORT OF 3 CASES AND A REVIEW OF THE LITERATURE
Authors: HOVENGA S DEWOLF JTM KLIP H VELLENGA E
Citation: S. Hovenga et al., CONSOLIDATION THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PLASMA-CELL LEUKEMIA AFTER VAD, HIGH-DOSE CYCLOPHOSPHAMIDE AND EDAP COURSES - A REPORT OF 3 CASES AND A REVIEW OF THE LITERATURE, Bone marrow transplantation, 20(10), 1997, pp. 901-904
A CASE OF LOCALIZED CASTLEMANS-DISEASE WITH SYSTEMIC INVOLVEMENT - TREATMENT AND PATHOGENETIC ASPECTS
Authors: VELDHUIS GJ VANDERLEEST AHD DEWOLF JTM DEVRIES EGE VELLENGA E
Citation: Gj. Veldhuis et al., A CASE OF LOCALIZED CASTLEMANS-DISEASE WITH SYSTEMIC INVOLVEMENT - TREATMENT AND PATHOGENETIC ASPECTS, Annals of hematology, 73(1), 1996, pp. 47-50
AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA AFTER VAD AND EDAP COURSES - A HIGH-INCIDENCE OF OLIGOCLONALITY POSTTRANSPLANTATION
Authors: VELLENGA E HOVENGA S MARRINK J GUIKEMA JEJ SMIT JW SIBINGA CTS BOS NA DEWOLF JTM
Citation: E. Vellenga et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION IN MULTIPLE-MYELOMA AFTER VAD AND EDAP COURSES - A HIGH-INCIDENCE OF OLIGOCLONALITY POSTTRANSPLANTATION, Blood, 88(10), 1996, pp. 514-514
IS MORTALITY-RATE WHAT IT IS ALL ABOUT IN CONGESTIVE-HEART-FAILURE
Authors: GIRBES ARJ DEWOLF JTM
Citation: Arj. Girbes et Jtm. Dewolf, IS MORTALITY-RATE WHAT IT IS ALL ABOUT IN CONGESTIVE-HEART-FAILURE, Lancet, 346(8988), 1995, pp. 1501-1502
LONG-TERM TREATMENT WITH INTERFERON-ALPHA-2B FOR SEVERE PRURITUS IN PATIENTS WITH POLYCYTHEMIA-VERA
Authors: MULLER EW DEWOLF JTM EGGER R WIJERMANS PW HUIJGENS PC HALIE MR VELLENGA E
Citation: Ew. Muller et al., LONG-TERM TREATMENT WITH INTERFERON-ALPHA-2B FOR SEVERE PRURITUS IN PATIENTS WITH POLYCYTHEMIA-VERA, British Journal of Haematology, 89(2), 1995, pp. 313-318
THE EFFECT OF CYCLOSPORINE ON HEMATOLOGICAL PARAMETERS IN PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA
Authors: VANKAMP H VANIMHOFF GW DEWOLF JTM SMIT JW HALIE MR VELLENGA E
Citation: H. Vankamp et al., THE EFFECT OF CYCLOSPORINE ON HEMATOLOGICAL PARAMETERS IN PATIENTS WITH PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA, British Journal of Haematology, 89(1), 1995, pp. 79-82
PRESTORAGE LEUKOCYTE DEPLETION IS NOT NECESSARILY REQUIRED FOR THE PREVENTION OF REFRACTORINESS TO PLATELET TRANSFUSION
Authors: DEWOLF JTM WESTERTERP A SIBINGA CTS HALIE MR
Citation: Jtm. Dewolf et al., PRESTORAGE LEUKOCYTE DEPLETION IS NOT NECESSARILY REQUIRED FOR THE PREVENTION OF REFRACTORINESS TO PLATELET TRANSFUSION, Blood, 86(8), 1995, pp. 3263-3263
ACUTE LYMPHOBLASTIC-LEUKEMIA - SINGLE-CENTER EXPERIENCE WITH MODIFIEDCHEMOTHERAPY
Authors: DAENEN S VANIMHOFF GW HAAXMAREICHE H VELLENGA E DEWOLF JTM HALIE MR
Citation: S. Daenen et al., ACUTE LYMPHOBLASTIC-LEUKEMIA - SINGLE-CENTER EXPERIENCE WITH MODIFIEDCHEMOTHERAPY, Blood, 86(10), 1995, pp. 3004-3004
OUTCOME OF A HYBRID CHEMOTHERAPY REGIMEN WITH MEDIASTINAL IRRADIATIONIN LEUKEMIC T-LYMPHOBLASTIC LYMPHOMA
Authors: DAENEN S VANIMHOFF GW HAAXMAREICHE H VELLENGA E DEWOLF JTM HALIE MR
Citation: S. Daenen et al., OUTCOME OF A HYBRID CHEMOTHERAPY REGIMEN WITH MEDIASTINAL IRRADIATIONIN LEUKEMIC T-LYMPHOBLASTIC LYMPHOMA, Blood, 86(10), 1995, pp. 3005-3005
SEVERE BLEEDING CAUSED BY AN INHIBITOR TO COAGULATION-FACTOR-V - A CASE-REPORT
Authors: SMID WM DEWOLF JTM NIJLAND JH BOM VJJ VANDERMEER J
Citation: Wm. Smid et al., SEVERE BLEEDING CAUSED BY AN INHIBITOR TO COAGULATION-FACTOR-V - A CASE-REPORT, Blood coagulation & fibrinolysis, 5(1), 1994, pp. 133-137
THE APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS IN DRUG-INDUCED AGRANULOCYTOSIS - A REVIEW OF 70 CASES
Authors: SPRIKKELMAN A DEWOLF JTM VELLENGA E
Citation: A. Sprikkelman et al., THE APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS IN DRUG-INDUCED AGRANULOCYTOSIS - A REVIEW OF 70 CASES, Leukemia, 8(12), 1994, pp. 2031-2036
THE EFFECTS OF IL-1 AND IL-4 ON THE EPO-INDEPENDENT ERYTHROID PROGENITOR IN POLYCYTHEMIA-VERA
Authors: DEWOLF JTM HENDRIKS DW ESSELINK MT HALIE MR VELLENGA E
Citation: Jtm. Dewolf et al., THE EFFECTS OF IL-1 AND IL-4 ON THE EPO-INDEPENDENT ERYTHROID PROGENITOR IN POLYCYTHEMIA-VERA, British Journal of Haematology, 88(2), 1994, pp. 242-246
PREVENTION OF REFRACTORINESS TO PLATELET TRANSFUSION BY THE USE OF NON-LEUKOCYTE DEPLETED STORED-BLOOD PRODUCTS
Authors: DEWOLF JTM WESTERTERP A HALIE MR
Citation: Jtm. Dewolf et al., PREVENTION OF REFRACTORINESS TO PLATELET TRANSFUSION BY THE USE OF NON-LEUKOCYTE DEPLETED STORED-BLOOD PRODUCTS, Blood, 84(10), 1994, pp. 10000667-10000667
MAST-CELL GROWTH-FACTOR MODULATES CD36 ANTIGEN EXPRESSION ON ERYTHROID PROGENITORS FROM HUMAN BONE-MARROW AND PERIPHERAL-BLOOD ASSOCIATED WITH ONGOING DIFFERENTIATION
Authors: DEWOLF JTM MULLER EW HENDRIKS DH HALIE RM VELLENGA E
Citation: Jtm. Dewolf et al., MAST-CELL GROWTH-FACTOR MODULATES CD36 ANTIGEN EXPRESSION ON ERYTHROID PROGENITORS FROM HUMAN BONE-MARROW AND PERIPHERAL-BLOOD ASSOCIATED WITH ONGOING DIFFERENTIATION, Blood, 84(1), 1994, pp. 59-64
Risultati: 1-25 | 26-31